brentuximab vedotin
Brentuximab vedotin in combination with doxorubicin, vincristine, etoposide, prednisone and cyclophosphamide in previously untreated high-risk HL in the pediatric population. Brentuximab vedotin in combination with doxorubicin, vinblastine, and dacarbazine for the treatment of previously untreated patients with advanced stage Hodgkins Lymphoma